These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1315160)

  • 1. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
    Tucker RM; Denning DW; Hanson LH; Rinaldi MG; Graybill JR; Sharkey PK; Pappagianis D; Stevens DA
    Clin Infect Dis; 1992 Jan; 14(1):165-74. PubMed ID: 1315160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azole antifungal agents.
    Bodey GP
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The triazole antifungal agents: a review of itraconazole and fluconazole.
    Bailey EM; Krakovsky DJ; Rybak MJ
    Pharmacotherapy; 1990; 10(2):146-53. PubMed ID: 2161523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral azole drugs as systemic antifungal therapy.
    Como JA; Dismukes WE
    N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antifungal agents for the systemic mycoses.
    Ringel SM
    Mycopathologia; 1990 Feb; 109(2):75-87. PubMed ID: 2157984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole antifungal drugs: old and new.
    Dismukes WE
    Ann Intern Med; 1988 Aug; 109(3):177-9. PubMed ID: 2839058
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic optimisation of oral antifungal therapy.
    Schäfer-Korting M
    Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.
    Tucker RM; Denning DW; Arathoon EG; Rinaldi MG; Stevens DA
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):593-601. PubMed ID: 2170479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal activities of azole agents against the Malassezia species.
    Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
    Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
    Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY
    Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy.
    Troke PF; Andrews RJ; Pye GW; Richardson K
    Rev Infect Dis; 1990; 12 Suppl 3():S276-80. PubMed ID: 2184505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole antifungal agents: emphasis on new triazoles.
    Saag MS; Dismukes WE
    Antimicrob Agents Chemother; 1988 Jan; 32(1):1-8. PubMed ID: 2831809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal agents. Part II. The azoles.
    Terrell CL
    Mayo Clin Proc; 1999 Jan; 74(1):78-100. PubMed ID: 9987539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antifungal agent resistance of yeasts of clinical significance].
    Odds FC
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():56-7. PubMed ID: 9441307
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
    Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azoles, allylamines and drug metabolism.
    Back DJ; Tjia JF; Abel SM
    Br J Dermatol; 1992 Feb; 126 Suppl 39():14-8. PubMed ID: 1311943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R 51211 (itraconazole) therapy of murine cryptococcosis.
    Graybill JR; Ahrens J
    Sabouraudia; 1984; 22(6):445-53. PubMed ID: 6098031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of ketoconazole and other azoles against Malassezia furfur in vitro and in vivo.
    Strippoli V; Piacentini A; D'Auria FD; Simonetti N
    Infection; 1997; 25(5):303-6. PubMed ID: 9334866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
    Viviani MA
    Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.